These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 18688711)

  • 21. Neuroprotective concentrations of the N-methyl-D-aspartate open-channel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning or long-term potentiation.
    Chen HS; Wang YF; Rayudu PV; Edgecomb P; Neill JC; Segal MM; Lipton SA; Jensen FE
    Neuroscience; 1998 Oct; 86(4):1121-32. PubMed ID: 9697119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The non-NMDA glutamate receptor antagonists 6-cyano-7-nitroquinoxaline-2,3-dione and 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(f)quinoxaline, but not NMDA antagonists, block the intrastriatal neurotoxic effect of MPP+.
    Merino M; Vizuete ML; Cano J; Machado A
    J Neurochem; 1999 Aug; 73(2):750-7. PubMed ID: 10428073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atorvastatin attenuates mitochondrial toxin-induced striatal degeneration, with decreasing iNOS/c-Jun levels and activating ERK/Akt pathways.
    Lee ST; Chu K; Park JE; Hong NH; Im WS; Kang L; Han Z; Jung KH; Kim MW; Kim M
    J Neurochem; 2008 Mar; 104(5):1190-200. PubMed ID: 17976163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calpain facilitates the neuron death induced by 3-nitropropionic acid and contributes to the necrotic morphology.
    Pang Z; Bondada V; Sengoku T; Siman R; Geddes JW
    J Neuropathol Exp Neurol; 2003 Jun; 62(6):633-43. PubMed ID: 12834108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential behavioural and neurochemical effects of competitive and non-competitive NMDA receptor antagonists in rats.
    Bubser M; Keseberg U; Notz PK; Schmidt WJ
    Eur J Pharmacol; 1992 Dec; 229(1):75-82. PubMed ID: 1361915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of NMDA receptor antagonists on cocaine-conditioned motor activity in rats.
    Bespalov AY; Dravolina OA; Zvartau EE; Beardsley PM; Balster RL
    Eur J Pharmacol; 2000 Mar; 390(3):303-11. PubMed ID: 10708738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compounds acting at the endocannabinoid and/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington's disease.
    Lastres-Becker I; de Miguel R; De Petrocellis L; Makriyannis A; Di Marzo V; Fernández-Ruiz J
    J Neurochem; 2003 Mar; 84(5):1097-109. PubMed ID: 12603833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glutamate N-methyl-D-aspartate and dopamine receptors have contrasting effects on the limbic versus the somatosensory cortex with respect to amphetamine-induced neurodegeneration.
    Bowyer JF; Delongchamp RR; Jakab RL
    Brain Res; 2004 Dec; 1030(2):234-46. PubMed ID: 15571672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of NR2B-containing N-methyl-D-aspartate receptors in haloperidol-induced c-Fos expression in the striatum and nucleus accumbens.
    Lee J; Rajakumar N
    Neuroscience; 2003; 122(3):739-45. PubMed ID: 14622917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3-Nitropropionic acid exacerbates N-methyl-D-aspartate toxicity in striatal culture by multiple mechanisms.
    Greene JG; Sheu SS; Gross RA; Greenamyre JT
    Neuroscience; 1998 May; 84(2):503-10. PubMed ID: 9539220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A dual role of adenosine A2A receptors in 3-nitropropionic acid-induced striatal lesions: implications for the neuroprotective potential of A2A antagonists.
    Blum D; Galas MC; Pintor A; Brouillet E; Ledent C; Muller CE; Bantubungi K; Galluzzo M; Gall D; Cuvelier L; Rolland AS; Popoli P; Schiffmann SN
    J Neurosci; 2003 Jun; 23(12):5361-9. PubMed ID: 12832562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modifications of the behavioral profile of non-competitive NMDA receptor antagonists, memantine, amantadine and (+)MK-801 after chronic administration.
    Hesselink MB; Smolders H; De Boer AG; Breimer DD; Danysz W
    Behav Pharmacol; 1999 Feb; 10(1):85-98. PubMed ID: 10780305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity.
    Volbracht C; van Beek J; Zhu C; Blomgren K; Leist M
    Eur J Neurosci; 2006 May; 23(10):2611-22. PubMed ID: 16817864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure of glycine site NMDA receptor antagonists to protect against L-2-chloropropionic acid-induced neurotoxicity highlights the uniqueness of cerebellar NMDA receptors.
    Widdowson PS; Gyte AJ; Upton R; Wyatt I
    Brain Res; 1996 Nov; 738(2):236-42. PubMed ID: 8955518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The novel non-competitive N-methyl-D-aspartate antagonist gacyclidine blocks the glutamate-induced release of hydroxyl radicals in the striatum under conditions in which dizocilpine does not. A microdialysis study in rats.
    Laplanche L; Kamenka JM; Barbanel G
    Neurosci Lett; 2000 Jul; 289(1):49-52. PubMed ID: 10899406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spermidine ameliorates 3-nitropropionic acid (3-NP)-induced striatal toxicity: Possible role of oxidative stress, neuroinflammation, and neurotransmitters.
    Jamwal S; Kumar P
    Physiol Behav; 2016 Mar; 155():180-7. PubMed ID: 26703234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroprotective effect of hemeoxygenase-1/glycogen synthase kinase-3β modulators in 3-nitropropionic acid-induced neurotoxicity in rats.
    Khan A; Jamwal S; Bijjem KR; Prakash A; Kumar P
    Neuroscience; 2015 Feb; 287():66-77. PubMed ID: 25536048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Creatine reduces 3-nitropropionic-acid-induced cognitive and motor abnormalities in rats.
    Shear DA; Haik KL; Dunbar GL
    Neuroreport; 2000 Jun; 11(9):1833-7. PubMed ID: 10884028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative analysis of the neuroprotective properties of competitive and uncompetitive N-methyl-D-aspartate receptor antagonists in vivo: implications for the process of excitotoxic degeneration and its therapy.
    Massieu L; Thedinga KH; McVey M; Fagg GE
    Neuroscience; 1993 Aug; 55(4):883-92. PubMed ID: 7694181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of pan- and subtype-selective N-methyl-D-aspartate receptor antagonists on cortical spreading depression in the rat: therapeutic potential for migraine.
    Peeters M; Gunthorpe MJ; Strijbos PJ; Goldsmith P; Upton N; James MF
    J Pharmacol Exp Ther; 2007 May; 321(2):564-72. PubMed ID: 17267580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.